Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
This grant opportunity funds the clinical validation of pharmacodynamic and toxicity markers. It is for applicants who have assays that have been analytically validated for use in clinical settings. The grant supports validation for up to 3 years, using specimens from existing or new clinical trials or studies. It does not fund early-stage technology development or the conduct of clinical tria…
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to accelerate the adoption and validation of molecular/cellular/imaging markers and assays for cancer detection, diagnosis, prognosis, monitoring, and prediction of response or resistance to treatment,…
Funding Source
Awards & funding
Eligibility
Foreign/Non-domestic entities: Non-domestic (non-U.S.) entities (foreign organizations) are NOT eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are NOT eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed within application…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers